June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
INHIBITORY ACTION OF MITOCHONDRIAL-TARGETING HYDROGEN SULFIDE RELEASING COMPOUNDS ON PORCINE ISOLATED IRIDES
Author Affiliations & Notes
  • Sunny E Ohia
    Department of Pharmaceutical Sciences, Texas Southern University, Houston, Texas, United States
  • Jenaye Robinson
    Department of Pharmaceutical Sciences, Texas Southern University, Houston, Texas, United States
  • Kalu Ngele
    Department of Pharmaceutical Sciences, Texas Southern University, Houston, Texas, United States
  • Matthew Whiteman
    Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, United Kingdom
  • Catherine A Opere
    Department of Pharmacy Sciences, Creighton University, Omaha, Nebraska, United States
  • Ya Fatou Njie-Mbye
    Department of Pharmaceutical Sciences, Texas Southern University, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Sunny Ohia, None; Jenaye Robinson, None; Kalu Ngele, None; Matthew Whiteman, None; Catherine Opere, None; Ya Fatou Njie-Mbye, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1073. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sunny E Ohia, Jenaye Robinson, Kalu Ngele, Matthew Whiteman, Catherine A Opere, Ya Fatou Njie-Mbye; INHIBITORY ACTION OF MITOCHONDRIAL-TARGETING HYDROGEN SULFIDE RELEASING COMPOUNDS ON PORCINE ISOLATED IRIDES. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1073.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We have previously reported that hydrogen sulfide (H2S)-releasing compounds can elicit relaxation of pre-contracted ocular vascular and non-vascular smooth muscles. In the present study, we compared the pharmacological actions of novel mitochondrial-targeting H2S-releasing compounds (AP39, AP123, and RT-01) with a non-mitochondria acting H2S releasing compound, ADT-OH in pre-contracted porcine isolated irides.

Methods : Isolated porcine iris muscle strips were set up in organ baths containing oxygenated Krebs buffer solution that is maintained at 37° C and gassed with 95% O2 and 5% CO2. The muscle strips were set to an initial resting tension of 0.15 g and longitudinal isometric tension was recorded via a grass FT03 Force-Displacement Transducers and analyzed using the PolyView computer software. Pharmacological actions of AP39, AP123 and RT-01 were assessed in the presence of tone induced by submaximal concentrations of the muscarinic agonist, carbachol. The cyclo-oxygenase inhibitor, flurbiprofen (10 µM) was added to Krebs buffer solution during the incubation period and was present for duration of the experiments. ADT-OH was used as a positive control in experiments using AP39, AP123 and RT-01 since it lacked the mitochondrial targeting moiety.

Results : The mitochondrial-targeting H2S-releasing compounds, AP39 (1 nM – 10 µM), RT-01 (1 nM – 10 µM) and AP123 (1 nM – 10 µM) elicited concentration-dependent relaxations of carbachol-induced tone. The rank order of activity was as follows (IC50): AP39, 50 nM (n = 10); RT-01, 100 nM (n = 4); and AP123, 300 nM (n = 4). Likewise, the non-mitochondrial-targeting H2S donor, ADT-OH (1 nM – 10 µM) caused a concentration-dependent relaxation of porcine irides with an IC50 of 50 nM (n = 8).

Conclusions : We conclude that both novel mitochondria-targeting H2S-releasing compounds and their control counterpart can elicit relaxation of isolated porcine irides. It appears that the inhibitory response caused by these H2S-releasing compounds in the porcine iris smooth muscle does not depend upon an effect on mitochondrial storage sites.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×